Over the last decade, and especially after the advent of fluorescent in situ hybridization imaging and Chromosome Conformation Capture methods, the availability of experimental data on genome three-dimensional (3D) organization has dramatically increased. We now have access to unprecedented details...

In response to a specific infrastructure call of the FP7 of the European Commission, BBMRI-LPC (Biobanking and Biomolecular Resources Research Infrastructure – Large Prospective Cohorts) a European-wide project involving 30 partners from 17...

The European three-dimensional (3D) genomics project entitled “Multi-scale complex genomics” (MuG) is coordinated by Dr. Modesto Orozco, at the Institute for Research in Biomedicine (IRB Barcelona) and it will be conducted over three years with a budget of 3 million euros. The goal is to...

Despite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data type and by disease. Individual efforts have little interoperability and almost no systematic connection of detailed clinical information with genetic information, biomaterial availability or...

The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million peopleworld-wide and cause considerable morbidity and mortality. Airways disease costs the European Union inexcess of €56 billion per annum. Current therapies are inadequate and we do not have sufficient...

BLUEPRINT, a new large-scale research project, will lead to targeted diagnostics, new treatments and preventive measures for specific diseases in individual patients; an approach known as 'personalised medicine'. BLUEPRINT, officially launched on 1 October 2011, is the European cornerstone of an...